1. Home
  2. PDM vs BCAX Comparison

PDM vs BCAX Comparison

Compare PDM & BCAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PDM
  • BCAX
  • Stock Information
  • Founded
  • PDM 1997
  • BCAX 2018
  • Country
  • PDM United States
  • BCAX United States
  • Employees
  • PDM N/A
  • BCAX N/A
  • Industry
  • PDM Building operators
  • BCAX
  • Sector
  • PDM Real Estate
  • BCAX
  • Exchange
  • PDM Nasdaq
  • BCAX NYSE
  • Market Cap
  • PDM 1.3B
  • BCAX 1.3B
  • IPO Year
  • PDM N/A
  • BCAX 2024
  • Fundamental
  • Price
  • PDM $9.44
  • BCAX $20.17
  • Analyst Decision
  • PDM Strong Buy
  • BCAX Strong Buy
  • Analyst Count
  • PDM 2
  • BCAX 4
  • Target Price
  • PDM $11.00
  • BCAX $41.00
  • AVG Volume (30 Days)
  • PDM 903.1K
  • BCAX 274.3K
  • Earning Date
  • PDM 10-24-2024
  • BCAX 11-12-2024
  • Dividend Yield
  • PDM 5.30%
  • BCAX N/A
  • EPS Growth
  • PDM N/A
  • BCAX N/A
  • EPS
  • PDM N/A
  • BCAX N/A
  • Revenue
  • PDM $572,424,000.00
  • BCAX N/A
  • Revenue This Year
  • PDM N/A
  • BCAX N/A
  • Revenue Next Year
  • PDM N/A
  • BCAX N/A
  • P/E Ratio
  • PDM N/A
  • BCAX N/A
  • Revenue Growth
  • PDM N/A
  • BCAX N/A
  • 52 Week Low
  • PDM $5.78
  • BCAX $18.33
  • 52 Week High
  • PDM $11.12
  • BCAX $28.09
  • Technical
  • Relative Strength Index (RSI)
  • PDM 33.55
  • BCAX N/A
  • Support Level
  • PDM $10.06
  • BCAX N/A
  • Resistance Level
  • PDM $10.45
  • BCAX N/A
  • Average True Range (ATR)
  • PDM 0.29
  • BCAX 0.00
  • MACD
  • PDM -0.10
  • BCAX 0.00
  • Stochastic Oscillator
  • PDM 1.53
  • BCAX 0.00

About PDM Piedmont Office Realty Trust Inc.

Piedmont Office Realty Trust Inc is a real estate investment trust engaged in the acquisition, development, and management of commercial real estate properties throughout the U.S. The company's real estate portfolio is mainly composed of office properties located in the majority of American metropolitan areas. Piedmont derives majority of its revenue in the form of rental income from tenants in mid- to long-term lease agreements. The vast majority of the company's revenue comes from the leasing of its assets in Washington D.C., New York City, Chicago, Atlanta, Minneapolis, Dallas, and Boston. Piedmont's large customers in terms of rental revenue are U.S. Government entities, business services companies, and financial institutions.

About BCAX BICARA THERAPEUTICS INC

Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b.

Share on Social Networks: